MedPath
NMPA Approval

Lurasidone Hydrochloride Tablets

国药准字HJ20230104

September 5, 2023

Drug Information

盐酸鲁拉西酮片

片剂

40mg(按C₂₈H₃₆N₄O₂S·HCl计)

化学药品

September 5, 2023

September 4, 2028

Company Information

Applicant Company

FTO-SEZ, Process Unit 01, Survey No. 57 to 59, 60, 62 &72, Sector No 9 to 14 & 17 to 20, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District-532409, Andhra Pradesh, India

Manufacturing Company

FTO-SEZ, Process Unit 01, Survey No. 57 to 59, 60, 62 & 72, Sector No 9 to 14 & 17 to 20, Devunipalavalasa Village, Ranasthalam Mandal, Srikakulam District-532409, Andhra Pradesh, India

© Copyright 2025. All Rights Reserved by MedPath
盐酸鲁拉西酮片 - NMPA 批准文号 | MedPath